日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

TCM soup can help cut COVID-19 death rate of patients in half, study shows

By WANG XIAOYU | CHINA DAILY | Updated: 2021-05-10 09:21
Share
Share - WeChat
Pharmacists dispense medicines according to Qingfei Paidu Soup prescriptions at Anhui University of Chinese Medicine on Feb 21, 2020. [Photo/Xinhua]

Qingfei paidu soup, a widely used traditional Chinese medicine to treat COVID-19 infections, can help reduce the rate of death among hospitalized patients by half, a recent study has shown.

The study examines more than 8,900 COVID-19 cases that received treatment at 15 hospitals in Hubei province-the hardest-hit region during the epidemic-from January to May last year, with nearly 30 percent of them having taken qingfei paidu as part of their therapies.

Results suggest that the mortality rate for those undergoing the TCM treatment stands at 1.2 percent, while the rate for other patients is 4.8 percent.

The study, led by researchers from Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, concluded that the use of qingfei paidu is associated with a 50 percent reduction of mortality in hospitalized COVID-19 patients, without amplifying the risk of developing acute liver or kidney injuries.

It was first published on preprint website MedRxiv.org in late December. On March 31, it was released on Phytomedicine, a peer-reviewed journal.

Li Jing, head of the research team, said based on the national diagnosis and treatment guideline for COVID-19 diseases, qingfei paidu is the only prescription that is recommended for treating all patients ranging from mild to critical cases.

"The extensive delivery of TCM medication in hospitalized patients during the outbreak had created a sound base for our research because when appraising clinical effectiveness of a certain drug, it is crucial to start by collecting and analyzing from a large enough number of cases," she said.

Qingfei paidu is a concoction that includes dozens of TCM herbs and roots, including ephedra, licorice root and bitter almond. The initial version of the prescription is believed to have originated during the Eastern Han Dynasty (25-220).

Zhang Boli, president of the Tianjin University of Traditional Chinese Medicine, said during an earlier interview that preliminary studies show the therapy mainly works on lungs while offering protection for some other organs against the virus. It can also stem the virus's replication, Zhang said.

According to the National Administration of Traditional Chinese Medicine, previous studies have already attested to the herbal prescription's efficacy in preventing mild and moderate cases from worsening into severe infections, but evidence of its role in lowering the death rate was lacking.

"The study is by far the largest clinical research on qingfei paidu and its findings have provided potent evidence for proving its marked efficacy in saving the lives of COVID-19 patients," the administration said.

As of now, there is no approved specific treatment for COVID-19 patients. During the fight against the epidemic, 92 percent of confirmed patients had undergone TCM therapies, with the efficacy rate in Hubei reaching 90 percent, according to a white paper released in June.

Li said the new study is retrospective and based on real-world cases.

"If a randomized, double-blind, placebo-controlled clinical study can be conducted in the future, the TCM drug's clinical efficacy can be further verified, and its global application is expected to expand," she added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 黄色短视频在线免费观看 | 成人在线免费av | 五月天婷五月天综合网站 | 亚洲精品久久久久一区二区三区 | 嫩草影院ncyy在线观看 | 亚洲乱码在线卡一卡二卡新区 | 亚洲亚洲人成综合网络 | 日韩亚洲视频 | 欧美综合久久 | 精品二区 | 日本天堂免费a | 99爱在线视频这里只有精品 | 一区二区三区在线 | 午夜影视在线观看免费完整高清大全 | 九九re6精品视频在线观看 | 性爱视频在线免费 | 欧美日韩精品一区二区 | 日本私人色多多 | 日韩卡1卡2 卡三卡2021老狼 | 奇米影视在线视频 | 色久在线 | 日韩在线免费看网站 | 日韩视频免费 | 久草综合在线视频 | 日本在线黄| 亚洲精品视频一区二区三区 | 6月婷婷| 成人小视频在线观看免费 | 亚洲视频在线视频 | 美女狠狠干| 草草视频手机在线观看视频 | 国产午夜精品久久久久小说 | 日本一本免费一二区 | 免费a级在线观看播放 | 99在线视频精品 | 成人午夜性a一级毛片美女 91精选 | 黄色av免费看 | 国产福利不卡视频在免费播放 | 久草视频国产 | 日本午夜免费无码片三汲大片 | 日本理论片中文在线观看2828 |